Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Harte-Hanks Q2 Adj EPS $0.16 Misses $0.20 Estimate, Sales $47.76M Miss $48.97M Estimate

Author: Benzinga Newsdesk | August 10, 2023 04:04pm
Harte-Hanks (NASDAQ:HHS) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.20 by 20 percent. This is a 69.23 percent decrease over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $47.76 million which missed the analyst consensus estimate of $48.97 million by 2.47 percent. This is a 1.63 percent decrease over sales of $48.55 million the same period last year.

Posted In: HHS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist